A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MTRX1011A in Patients With Rheumatoid Arthritis

This study has been terminated.

(Study had completed enrollment but drug injection was halted due to an unacceptable incidence of rash.)

Sponsor:

Information provided by (Responsible Party):

Genentech

ClinicalTrials.gov Identifier:

NCT00718588

First received: July 16, 2008

Last updated: March 6, 2012

Last verified: March 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	No date given
Primary Completion Date:	December 2009 (Final data collection date for primary outcome measure)